KYNB · Kyntra Bio, Inc.

$7.07 -0.15 (-2.01%) At close · Jul 23

Market Cap

$28.46M

4.05M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Enrique Conterno	CEO	$875,000	—	$4,490,726	$2,030,274	—	$41,427	$7,437,427
Thane Wettig	CEO	$573,334	—	$1,670,156	$1,028,878	$321,527	$46,934	$3,640,829
Mark Eisner	Chief Medical Officer	$650,000	—	$1,711,004	$780,329	—	$51,212	$3,192,545
Christine L. Chung	Senior Vice President, China Operations	$515,000	—	$1,432,544	$765,222	$225,776	$174,586	$3,113,128
Juan Graham	CFO	$505,000	—	$1,432,544	$765,222	$220,685	$166,803	$3,090,254

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Enrique Conterno	CEO	$850,000	—	$6,443,375	$2,779,684	$603,713	$64,302	$10,741,074
Mark Eisner	Chief Medical Officer	$630,000	—	$2,154,975	$932,780	$304,243	$58,710	$4,080,708
Christine L. Chung	Senior Vice President, China Operations	$505,000	—	$1,616,231	$699,585	$241,668	$528,070	$3,590,554
Thane Wettig	CEO	$535,000	—	$1,616,231	$699,585	$253,483	$18,862	$3,123,161
Juan Graham	CFO	$480,000	$150,000	$808,116	$349,793	$226,848	$284,909	$2,299,666

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Enrique Conterno	CEO	$825,000	—	$4,346,820	$4,732,876	$422,297	$58,110	$10,385,103
Christine L. Chung	Senior Vice President, China Operations	$490,000	—	$1,688,225	$2,031,863	$180,707	$336,349	$4,727,144
Mark Eisner	Chief Medical Officer	$600,000	$1,000,000	$739,984	$1,157,212	$218,100	$52,310	$3,767,606
Pat Cotroneo	CFO	$515,000	—	$1,150,317	$1,845,874	$187,718	$57,824	$3,756,733
Elias Kouchakji	Senior Vice President, Clinical Development, Drug Safety and Pharmacovigilance	$213,750	—	$1,102,608	$1,766,492	—	$103,257	$3,186,107
Thane Wettig	CEO	$510,000	—	$874,665	$1,590,542	$186,533	$12,855	$3,174,595
Juan Graham	CFO	$149,546	$150,000	$434,350	$1,446,166	$55,716	$22,179	$2,257,957

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Enrique Conterno	CEO	$790,909	$250,000	$2,601,000	$8,024,850	$554,400	$46,460	$12,267,619
Thane Wettig	CEO	$263,258	$150,000	$1,262,400	$2,159,568	$122,158	$47,610	$4,004,994
Mark Eisner	Chief Medical Officer	$50,000	$500,000	$1,443,750	$1,919,616	—	$4,291	$3,917,657
K. Peony Yu	Chief Medical Officer	$612,000	—	$1,188,450	$1,201,950	$459,000	$51,364	$3,512,764
Pat Cotroneo	CFO	$508,000	—	$1,056,400	$1,061,723	$230,937	$58,959	$2,916,018
Elias Kouchakji	Senior Vice President, Clinical Development, Drug Safety and Pharmacovigilance	$570,000	—	$990,375	$1,001,625	$259,065	$64,215	$2,885,280
Christine L. Chung	Senior Vice President, China Operations	$480,000	—	$1,056,400	$1,061,723	$233,568	$47,916	$2,879,607
James A. Schoeneck	CEO	$200,000	—	—	—	—	$517,343	$717,343

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas B. Neff	CEO	$687,115	—	$5,366,088	$5,333,469	—	$20,800	$11,407,472
K. Peony Yu	Chief Medical Officer	$590,000	—	$3,044,223	$1,886,018	$316,830	$19,380	$5,856,451
James A. Schoeneck	CEO	$564,103	—	$2,347,008	$2,329,934	—	$6,920	$5,247,964
Drug Safety	and Pharmacovigilance	$550,000	—	$2,424,486	$1,697,417	$292,600	$20,586	$4,985,088
Elias Kouchakji	Senior Vice President, Clinical Development, Drug Safety and Pharmacovigilance	$550,000	—	$2,424,486	$1,697,417	$292,600	$20,586	$4,985,088
Christine L. Chung	Senior Vice President, China Operations	$440,000	—	$2,522,520	$1,366,680	$243,320	$17,766	$4,590,286
Pat Cotroneo	CFO	$490,000	—	$1,782,963	$1,769,851	$264,600	$18,972	$4,326,386
Mark Eisner	Chief Medical Officer	—	—	—	—	—	—	—
Thane Wettig	CEO	—	—	—	—	—	—	—
Enrique Conterno	CEO	—	—	—	—	—	—	—

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas B. Neff	CEO	$875,000	—	$3,762,500	$3,715,635	$847,875	$23,034	$9,224,044
K. Peony Yu	Chief Medical Officer	$564,000	—	$1,720,000	$1,857,818	$371,394	$19,152	$4,532,364
Pat Cotroneo	CFO	$471,000	—	$1,505,000	$1,283,583	$294,281	$17,662	$3,571,526
Mark Eisner	Chief Medical Officer	—	—	—	—	—	—	—
Drug Safety	and Pharmacovigilance	—	—	—	—	—	—	—
Thane Wettig	CEO	—	—	—	—	—	—	—
Enrique Conterno	CEO	—	—	—	—	—	—	—
James A. Schoeneck	CEO	—	—	—	—	—	—	—

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas B. Neff	CEO	$840,000	—	$2,684,780	$2,850,751	$693,000	$20,160	$7,088,691
K. Peony Yu	Chief Medical Officer	$525,000	—	$1,045,870	$1,154,818	$393,750	$18,331	$3,137,769
Pat Cotroneo	CFO	$453,000	—	$971,169	$1,072,331	$249,150	$17,276	$2,762,926

Key facts CIK 921299 CUSIP 31572Q881 13F (30d) 1 filings 1 filers Visit website